PolyNovo Limited

ASX:PNV Stock Report

Market Cap: AU$721.9m

PolyNovo Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Bruce Peatey

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

Narrative Update Apr 24

PNV: Fine Tuned Assumptions Will Support Stable Outlook And Balanced Upside Potential

Analysts have adjusted their A$ price target on PolyNovo, reflecting updated assumptions for discount rate, revenue growth, profit margin and future P/E. You should view this as a fine tuning of their outlook rather than a major reset.
Narrative Update Apr 10

PNV: Higher Margin Outlook And Adjusted Assumptions Will Support Balanced Upside Potential

Analysts have lifted their price target on PolyNovo to A$X.X0 from A$Y.Y0. The change reflects slightly higher assumptions for long term revenue growth and profit margins, a modestly higher discount rate, and a marginally lower future P/E multiple.
Narrative Update Mar 26

PNV: Higher Margin Outlook And Steady P E Assumption Will Support Upside Potential

Analysts have slightly increased their A$ price target for PolyNovo, citing updated assumptions for revenue growth, profit margins and future P/E that together support a modestly higher valuation outlook. Valuation Changes Fair Value: A$ fair value input is unchanged at 1.0. Discount Rate: Discount rate has edged down slightly from 7.58% to 7.58%.
Narrative Update Mar 11

PNV: Refined Profitability And P E Assumptions Will Support Balanced Future Returns

Analysts have slightly adjusted their valuation work on PolyNovo, trimming the implied P/E multiple and updating growth and profitability assumptions. This has led to a modest change in their A$ price target while keeping the overall fair value view broadly in line with prior estimates.
Narrative Update Feb 25

PNV: Updated Profitability Assumptions Will Support Balanced Future Return Potential

Analysts have revised their PolyNovo price target from A$1.25 to A$1.00, citing updated assumptions for revenue growth, margins, and future P/E that they view as more consistent with current expectations. Valuation Changes Fair Value: Reduced from A$1.25 to A$1.00, which implies a lower central estimate for the share price.
Narrative Update Feb 10

PNV: Refined Earnings Assumptions Will Support Steady Fair Value Upside

Analysts have reaffirmed their A$1.25 price target for PolyNovo, with only slight tweaks to the discount rate, revenue growth, profit margin and assumed future P/E. This reflects fine tuning of their valuation rather than a major change in view.
Analysis Article Feb 07

PolyNovo Limited (ASX:PNV) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless

PolyNovo Limited ( ASX:PNV ) shareholders that were waiting for something to happen have been dealt a blow with a 27...
Narrative Update Jan 27

PNV: Earnings Outlook Will Support Steady Fair Value And Upside Potential

Analysts have kept their PolyNovo fair value unchanged at A$1.25, with small tweaks to assumptions for discount rate, revenue growth, profit margin and future P/E, reflecting slightly updated views on the risk profile and earnings outlook. Valuation Changes Fair Value: Kept unchanged at A$1.25 per share, indicating no change to the anchor valuation level.
Narrative Update Jan 12

PNV: Revenue Outlook And Margins Will Support Steady Fair Value Expectations

Analysts have kept their price target for PolyNovo unchanged at A$1.25. Slight adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E multiple have contributed to maintaining this view.
Narrative Update Dec 13

PNV: Revenue Outlook And Margins Will Support Measured Future Share Performance

Analysts have modestly raised their price target on PolyNovo from A$1.20 to A$1.25, citing expectations for faster revenue growth, slightly higher profit margins, and a marginally lower future P E multiple despite a small increase in the discount rate. Valuation Changes Fair Value: Risen slightly from A$1.20 to A$1.25, reflecting a modest uplift in the central valuation estimate.
Narrative Update Nov 29

PNV: Future P/E and Discount Rate Shift Will Support Upside Momentum

Analysts have raised their price target for PolyNovo from $1.97 to $1.98 per share, citing slight adjustments to the discount rate and future price-to-earnings assumptions. What's in the News PolyNovo Limited (ASX:PNV) has been dropped from the S&P/ASX 200 Index (Key Developments) Valuation Changes Fair Value: Increased marginally to A$1.98 per share from A$1.97.
Narrative Update Nov 15

PNV: Discount Rate Adjustment Will Support Positive Investor Sentiment

Analysts have slightly raised their price target for PolyNovo to $1.97. They cited minor adjustments to the company's discount rate while maintaining their outlook on revenue growth and profit margins.
Narrative Update Nov 01

PNV: Improved Margins And Expansion Efforts Will Drive Future Upside

Analysts have maintained their price target for PolyNovo at $1.97, reflecting a largely unchanged outlook. Modest improvements in revenue growth and profit margin offset a slight increase in discount rate assumptions.
Narrative Update Oct 18

International Expansion And Regulatory Approvals Will Unlock New Markets

Analysts have maintained PolyNovo's fair value price target at $1.97. This reflects continued confidence in the company's prospects despite minor adjustments to certain financial assumptions.
Narrative Update Oct 04

International Expansion And Regulatory Approvals Will Unlock New Markets

Analysts have raised their fair value price target for PolyNovo from $1.81 to $1.97 per share. This change reflects slight improvements in projected revenue growth and a marginally lower discount rate.
Analysis Article Sep 28

At AU$1.38, Is PolyNovo Limited (ASX:PNV) Worth Looking At Closely?

While PolyNovo Limited ( ASX:PNV ) might not have the largest market cap around , it led the ASX gainers with a...
Analysis Article Sep 11

PolyNovo Limited (ASX:PNV) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable

The PolyNovo Limited ( ASX:PNV ) share price has done very well over the last month, posting an excellent gain of 26...
Narrative Update Aug 26

NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects

The consensus price target for PolyNovo has been revised downward to A$1.80, reflecting a notable drop in its future P/E multiple despite an improvement in net profit margin. Valuation Changes Summary of Valuation Changes for PolyNovo The Consensus Analyst Price Target has fallen from A$1.98 to A$1.80.
Analysis Article Jul 18

Returns Are Gaining Momentum At PolyNovo (ASX:PNV)

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Analysis Article Jun 13

An Intrinsic Calculation For PolyNovo Limited (ASX:PNV) Suggests It's 38% Undervalued

Key Insights PolyNovo's estimated fair value is AU$1.92 based on 2 Stage Free Cash Flow to Equity Current share price...
Analysis Article May 22

PolyNovo Limited's (ASX:PNV) 25% Jump Shows Its Popularity With Investors

Those holding PolyNovo Limited ( ASX:PNV ) shares would be relieved that the share price has rebounded 25% in the last...
Analysis Article May 08

Is There Now An Opportunity In PolyNovo Limited (ASX:PNV)?

PolyNovo Limited ( ASX:PNV ), is not the largest company out there, but it saw a significant share price rise of 51% in...
User avatar
New Narrative Mar 11

NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects

Launch of NovoSorb MTX in the U.S. and geographic expansion could drive revenue growth and diversify revenue sources.
Analysis Article Mar 03

PolyNovo (ASX:PNV) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Investors were disappointed with PolyNovo Limited's ( ASX:PNV ) earnings, despite the strong profit numbers. We think...
Analysis Article Feb 26

PolyNovo Limited's (ASX:PNV) Share Price Is Still Matching Investor Opinion Despite 37% Slump

The PolyNovo Limited ( ASX:PNV ) share price has fared very poorly over the last month, falling by a substantial 37...
Analysis Article Feb 11

An Intrinsic Calculation For PolyNovo Limited (ASX:PNV) Suggests It's 39% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, PolyNovo fair value estimate is AU$2.98 PolyNovo is estimated...
Analysis Article Oct 10

Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

PolyNovo Limited ( ASX:PNV ), is not the largest company out there, but it received a lot of attention from a...
Analysis Article Aug 28

PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Aug 06

PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

You may think that with a price-to-sales (or "P/S") ratio of 19.1x PolyNovo Limited ( ASX:PNV ) is a stock to avoid...
Analysis Article May 08

PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

You may think that with a price-to-sales (or "P/S") ratio of 18.9x PolyNovo Limited ( ASX:PNV ) is a stock to avoid...
Analysis Article Feb 28

When Should You Buy PolyNovo Limited (ASX:PNV)?

While PolyNovo Limited ( ASX:PNV ) might not have the largest market cap around , it received a lot of attention from a...
Analysis Article Feb 02

Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S

With a price-to-sales (or "P/S") ratio of 20.8x PolyNovo Limited ( ASX:PNV ) may be sending very bearish signals at the...
Analysis Article Jan 08

PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate

Key Insights PolyNovo's estimated fair value is AU$2.90 based on 2 Stage Free Cash Flow to Equity PolyNovo's AU$1.54...
Analysis Article Sep 22

Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jun 26

When Should You Buy PolyNovo Limited (ASX:PNV)?

PolyNovo Limited ( ASX:PNV ), might not be a large cap stock, but it saw significant share price movement during recent...
Analysis Article May 30

Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?

Key Insights PolyNovo's estimated fair value is AU$2.17 based on 2 Stage Free Cash Flow to Equity PolyNovo is estimated...
Analysis Article Apr 18

Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price

With a price-to-sales (or "P/S") ratio of 22.3x PolyNovo Limited ( ASX:PNV ) may be sending very bearish signals at the...
Analysis Article Mar 23

Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?

PolyNovo Limited ( ASX:PNV ), is not the largest company out there, but it received a lot of attention from a...

CEO

Bruce Peatey

less than a year
Tenure

Mr. Bruce Peatey is Chief Executive Officer of PolyNovo Limited from December 1, 2025. Mr. Peatey was Group Vice President for APAC RCO of DENTSPLY SIRONA Inc. He was Vice President of Marketing of Abbott...


Leadership Team

NamePositionTenureCompensationOwnership
Jan-Marcel Gielen
CFO & Company Secretary7.4yrsAU$387.69k0.064%
A$ 465.0k
Bruce Peatey
Chief Executive Officerless than a yearno datano data
Amy Demediuk
Company Secretary & General Counselless than a yearno datano data
Kimberley Axon
Chief People Officer1.3yrsno datano data
Edward Graubart
President of North America6.7yrsno datano data
Ahmed Hassan
Chief Manufacturing & Supply Chain Officer2.3yrsno datano data
1.8yrs
Average Tenure

Experienced Management: PNV's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Robert Douglas
Non-Executive Directorless than a yearno data0.022%
A$ 157.8k
Andrew Lumsden
Independent Non-Executive Director4.9yrsAU$117.73k0.029%
A$ 209.0k
Leon Hoare
Independent Non-executive Chair10.3yrsAU$106.58k0.17%
A$ 1.2m
Christine Emmanuel-Donnelly
Independent Non-Executive Director6yrsAU$114.94k0.039%
A$ 283.0k
Charmaine Gittleson
Independent Non-Executive Directorless than a yearno datano data
4.9yrs
Average Tenure

Experienced Board: PNV's board of directors are considered experienced (4.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/20 04:33
End of Day Share Price 2026/05/20 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PolyNovo Limited is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Lyanne HarrisonBofA Global Research
Shane StoreyCanaccord Genuity